About Oncospace
Oncospace is a company based in Baltimore (United States) founded in 2018 was acquired by Sun Nuclear in April 2025. Oncospace has raised $900 thousand across 1 funding round from investors including Sun Nuclear. Oncospace offers products and services including Predictive Planning and Patient Data Conversion.
- Headquarter Baltimore, United States
- Email••••••••
- Website oncospace.com
- Social LinkedIn
- Acquired by Sun Nuclear (Apr 2025)
- Legal Name Oncospace, Inc
- Total Equity Funding$900K (USD)
in 1 rounds
- Latest Funding Round$900K (USD), Seed
May 2019
- Investors
- Acquired bySun Nuclear
(Apr 2025)
Products & Services of Oncospace
Oncospace offers a comprehensive portfolio of products and services, including Predictive Planning and Patient Data Conversion.
Predictive Planning is utilized as an AI-driven platform that assists in generating achievable treatment plans for radiation oncology.
Patient Data Conversion is employed as a service that facilitates the seamless transfer and management of patient information in radiation oncology practices.
Funding Insights of Oncospace
Oncospace has successfully raised a total of $900K through 1 strategic funding round. The most recent funding activity was a Seed round of $900 thousand completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $900,000
- Total Rounds 1
- Last Round Seed — $900,000
- First Round $900,000
(May 2019)
All 1 funding rounds of Oncospace with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2019 | $900,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Oncospace
Oncospace has secured backing from 1 investor. Prominent investors backing the company include Sun Nuclear.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Patient safety solutions for cancer diagnosis and treatment are developed. | 1984 | sunnuclear.com | Melbourne, United States |
Investor details for Oncospace
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Oncospace
4 people are tracked at Oncospace (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Todd McNutt | Chief Scientist | Leadership |
Michael Bowers | Director of Product Development | Leadership |
Colleen Donnelly | Director Of Finance And HR | Leadership |
Saida Muktar | Data Scientist | Team |
Complete people profiles for Oncospace
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oncospace
3 dated milestones of Oncospace across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Oncospace is founded.
- Funding First funding round of $900K.
- Exit Acquired by Sun Nuclear.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oncospace
Oncospace was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Oncospace is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Oncospace is a funded company, having raised a total of $900K across 1 funding round to date. The company's 1st funding round was a Seed of $900K, raised on May 2019.
Oncospace offers Predictive Planning, Patient Data Conversion while focusing on providing healthcare solutions. Provider of healthcare solutions focused on cancer patients. Delivering reliable solutions, it emphasizes quality and efficiency. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
Oncospace offers Predictive Planning and Patient Data Conversion.
Oncospace has 1 investor. Key investors include Sun Nuclear.
Oncospace operates through Oncospace, Inc.
Yes. Oncospace was acquired by Sun Nuclear in April 2025.